DNA, 23andMe and Regeneron
Digest more
Top News
Overview
Impacts
Mounting evidence from genome studies indicates that, contrary to received wisdom, our species has undergone profound biological adaptation in its recent evolutionary past
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
If DNA bridges persist between chromosomes during cell division, chromosomes are abnormally segregated, leading to genetic instability and cancer. Researchers at UNIST and IBS have experimentally revealed for the first time how a critical protein acts as a last resort to eliminate these dangerous DNA bridges,
Explore more
Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor proliferation and cortical size. Small genetic changes in HARE5 amplify a key developmental pathway,
Wonderbot on MSN9h
After 6 Decades of Searching for Her Birth Father, One DNA Report Changed Her LifeAfter 60 years of unanswered questions, one woman’s search for her birth father finally ends—with a single DNA report that changes everything. This moving story reveals how modern science can unlock long-lost family connections and reshape lives.
Thao Xiong, 59, already faced a January charge of raping a 71-year-old in St. Paul. He’s been on probation since 2020 for a 2019 sexual assault.